-
Mashup Score: 0Anita Mamtani on Axillary Dissection: For What Types of Breast Cancer Can It Be Avoided - The ASCO Post - 11 month(s) ago
Kari M. Rosenkranz, MD, on Breast Cancer: Impact of Breast Conservation on Local Recurrence Kari M. Rosenkranz, MD, of Dartmouth Health, discusses findings from the ACOSOG Z11102 (Alliance) study, which showed that breast-conserving therapy is safe for patients with multiple ipsilateral breast cancer lesions, resulting in low recurrence rates. However, omitting adjuvant endocrine therapy…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Judy Boughey on Changes in Axillary Surgical Management An ISPY2 Analysis - The ASCO Post - 11 month(s) ago
2023 Society of Surgical Oncology International Conference on Surgical Cancer Care Judy C. Boughey, MD, of the Mayo Clinic, discusses the decrease, over the past decade, of axillary lymph node dissection, especially in patients with node-positive breast cancer at diagnosis who had sentinel lymph node surgery after neoadjuvant chemotherapy. These findings are based on the…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 02023 SSO Annual Meeting - 11 month(s) ago
Thank You for Making SSO 2023 a Success! We look forward to seeing you at SSO 2024 in Atlanta.
Source: www.eventscribe.netCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Neoadjuvant Pembrolizumab in Desmoplastic Melanoma - The ASCO Post - 11 month(s) ago
Neoadjuvant pembrolizumab may significantly improve the management of desmoplastic melanoma, increasing the likelihood of successful resection and reducing the need for further surgery or radiation therapy, according to the response data presented at the 2022 ASCO Annual Meeting, with the surgical considerations presented at the 2023 Society of Surgical Oncology (SSO) International Conference on…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Using Circulating Tumor DNA to Predict Early Recurrence of Soft-Tissue Sarcomas - The ASCO Post - 11 month(s) ago
Circulating tumor DNA (ctDNA) may transform disease monitoring and guide treatment for soft-tissue sarcomas, according to data presented at the 2023 Society of Surgical Oncology (SSO) International Conference on Surgical Cancer Care.1 Findings of a retrospective review showed that 85% of patients with documented disease progression or recurrence had ctDNA levels rise accordingly, and all patients…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ExpertEd - 11 month(s) ago
ExpertEd from Society of Surgical Oncology
Source: experted.surgonc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Neoadjuvant Pembrolizumab in Desmoplastic Melanoma - The ASCO Post - 12 month(s) ago
By Chase Doyle Posted: 4/6/2023 11:00:00 AM Last Updated: 4/6/2023 12:00:36 PM Neoadjuvant pembrolizumab may significantly improve the management of desmoplastic melanoma, increasing the likelihood of successful resection and reducing the need for further surgery or radiation therapy, according to the…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6ExpertEd - 1 year(s) ago
ExpertEd from Society of Surgical Oncology
Source: experted.surgonc.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
#SSO2023 brings two more melanoma podcasts soon to be available at https://t.co/c2Q2J3a1fj @SocSurgOnc https://t.co/mWEyArTu5H
-
-
Mashup Score: 3Robotic Portal Lymphadenectomy: A Standardized Approach - 1 year(s) ago
This is a narrated and edit robotic portal lymphadenectomy performed during oncologic surgery for an incidental gallbladder cancer. This video will be shared…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 13Introducing SSO’s New Strategic Plan - 1 year(s) ago
Directing the Future of Cancer Care SSO Strategic Plan SSO is excited to introduce the new 2023 – 2027 Strategic Plan. This plan is a culmination hundreds of hours of time contributed by 215 SSO members from around the globe. These dedicated individuals served the Society in a variety of ways including task force and … Introducing SSO’s New Strategic Plan Read More »
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Anita Mamtani, MD, on Axillary Dissection: For What Types of Breast Cancer Can It Be Avoided? https://t.co/2lCc7eLZpo #bcsm #breastcancer #SSO2023 @MSKCancerCenter #oncology #surgonc